Seminars in Radiation Oncology
Volume 19, Issue 4 , Pages 195-203 , October 2009

Epidemiology of Locally Advanced Breast Cancer

  • Lisa A. Newman, MD, MPH, FACS

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Lisa A. Newman, MD, MPH, FACS, Breast Care Center, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109

References 

  1. Haagensen C, Stout A. Carcinoma of the breast II (Criteria of operability). Ann Surg. 1943;118:859
  2. Haagensen CD. Diseases of the Breast. Philadelphia: Saunders; 1956;
  3. Bonadonna G, Veronesi U, Brambilla C, et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst. 1990;82:1539–1545
  4. Benchmark Reports, V. 9.0. National Cancer Data Base, Commission on Cancer, American College of Surgeons, 2009. http://www.facs.org/cancer/publicncdb.htmlAccessed May 1, 2009
  5. Ries L, Melbert D, Krapcho M, et al. SEER cancer statistics (ReView, 1975-2005). Posted to SEER website http://seer.cancer.gov/csr/1975_2005Accessed May 1, 2009
  6. American Cancer Society. Breast Cancer Facts and Figures 2007-2008. Atlanta, GA: American Cancer Society, Inc; 2009;
  7. Wolmark N, Wang J, Mamounas E, et al. Preoperative chemotherapy in patients with operable breast cancer: Nine-year results from national surgical adjuvant breast and bowel project B18. J Natl Cancer Inst Monogr. 2001;30:96–102
  8. Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817–2826
  9. Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005;97:439–448
  10. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78–93
  11. US Census Bureau, Population Division. Population Projections Branch, Maintained by Information and research services. http://www.census.gov/ipc/www/usinterimproj/Accessed May 1, 2009
  12. Hance KW, Anderson WF, Devesa SS, et al. Trends in inflammatory breast carcinoma incidence and survival: The Surveillance, Epidemiology and End Results Program at the National Cancer Institute. J Natl Cancer Inst. 2005;97:966–975
  13. Joslyn SA, Foote ML, Nasseri K, et al. Racial and ethnic disparities in breast cancer rates by age: NAACCR breast cancer project. Breast Cancer Res Treat. 2005;92:97–105
  14. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78–93
  15. Clegg LX, Li FP, Hankey BF, et al. Cancer survival among US whites and minorities: A SEER (surveillance, epidemiology, and end results) program population-based study. Arch Intern Med. 2002;162:1985–1993
  16. Gorin SS, Heck JE, Cheng B, et al. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med. 2006;166:2244–2252
  17. Anderson WF, Chatterjee N, Ershler WB, et al. Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database. Breast Cancer Res Treat. 2002;76:27–36
  18. Thomson CS, Hole DJ, Twelves CJ, et al. Prognostic factors in women with breast cancer: Distribution by socioeconomic status and effect on differences in survival. J Epidemiol Community Health. 2001;55:308–315
  19. Lee MC, et al. Increased Frequency Estrogen Receptor (ER) Negative and Aneuploid Breast Cancer in African American Women at All Stages of Disease: First Analysis From the National Cancer Database. P-PLB, KI New York, NY: Society of Surgical Oncology; 2007;
  20. Newman LA, Griffith KA, Jatoi I, et al. Meta-analysis of survival in African American and white American patients with breast cancer: Ethnicity compared with socioeconomic status. J Clin Oncol. 2006;24:1342–1349
  21. Carnon AG, Ssemwogerere A, Lamont DW, et al. Relation between socioeconomic deprivation and pathological prognostic factors in women with breast cancer. BMJ. 1994;309:1054–1057
  22. Halmin M, Bellocco R, Lagerlund M, et al. Long-term inequalities in breast cancer survival—A ten year follow-up study of patients managed within a National Health Care System (Sweden). Acta Oncol. 2008;47:216–224
  23. Globocan: International Agency for Research on Cancer. http://www.isradiology.org/education/globocan%202002%20database/view.htmAccessed May 1, 2009
  24. Tan EY, Wong HB, Ang BK, et al. Locally advanced and metastatic breast cancer in a tertiary hospital. Ann Acad Med Singapore. 2005;34:595–601
  25. Omar S, Khaled H, Gaafar R, et al. Breast cancer in Egypt: A review of disease presentation and detection strategies. East Mediterr Health J. 2003;9:448–463
  26. El Saghir NS, Khalil MK, Eid T, et al. Trends in epidemiology and management of breast cancer in developing Arab countries: A literature and registry analysis. Int J Surg. 2007;5:225–233
  27. Agarwal G, Pradeep PV, Aggarwal V, et al. Spectrum of breast cancer in Asian women. World J Surg. 2007;31:1031–1040
  28. Bird PA, Hill AG, Houssami N. Poor hormone receptor expression in East African breast cancer: Evidence of a biologically different disease?. Ann Surg Oncol. 2008;15:1983–1988
  29. Fregene A, Newman LA. Breast cancer in sub-Saharan Africa: How does it relate to breast cancer in African-American women?. Cancer. 2005;103:1540–1550
  30. El Saghir NS, Eniu A, Carlson RW, et al. Locally advanced breast cancer: Treatment guideline implementation with particular attention to low- and middle-income countries. Cancer. 2008;113(suppl):2315–2324
  31. Fan L, Zheng Y, Yu KD, et al. Breast cancer in a transitional society over 18 years: Trends and present status in Shanghai. China: Breast Cancer Res Treat; 2009;[Epub ahead of print]
  32. US Census Bureau. Current population survey, 2002-04 (Annual Social and Economic Supplements, Washington, D. C.). 2004;
  33. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163:49–56
  34. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina breast cancer study. J Am Med Assoc. 2006;295:2492–2502
  35. Morris GJ, Naidu S, Topham AK, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: A single-institution compilation compared with the National Cancer Institute's surveillance, epidemiology, and end results database. Cancer. 2007;110:876–884
  36. Lund MJ, Trivers KF, Porter PL, et al. Race and triple negative threats to breast cancer survival: A population-based study in Atlanta, Ga. Breast Cancer Res Treat. 2009;113:357–370
  37. Lund MJ, Butler EN, Bumpers HL, et al. High prevalence of triple-negative tumors in an urban cancer center. Cancer. 2008;113:608–615
  38. Moran MS, Yang Q, Harris LN, et al. Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer. Cancer. 2008;113:2565–2574

PII: S1053-4296(09)00039-3

doi: 10.1016/j.semradonc.2009.05.003

Seminars in Radiation Oncology
Volume 19, Issue 4 , Pages 195-203 , October 2009

Article Tools

* Image Usage & Resolution